NSE / BSEHealthcare
β‚Ή192.45-2.55-1.31%
P/E27.2Mkt Capβ‚Ή9.55 K CrEV/EBITDA17.6

JYOTHY LABS LIMITED

P/E27.2Mkt Capβ‚Ή9.55 K CrEV/EBITDA17.6
Company Profile

Jyothy Labs Limited, together with its subsidiaries, manufactures and markets fabric care, dishwashing, personal care, and household insecticides products in India and internationally. It operates through Dishwashing, Fabric Care, Household Insecticides, Personal Care, and Others segments. The Dishwashing segment offers dish wash bars, gels, and liquids, as well as dish wash scrubbers, steel scrubbers, and powders under the Pril and Exo brands. The Fabric Care segment provides fabric whiteners, enhancers, and conditioner; detergent powders; and detergent liquids and bar soaps under the Henko, Mr. White, Ujala, and More light brands. The Household Insecticides segment offers mosquito repellent coils, aerosol, liquids, and racquet, as well as surface cleaners and air care products under the Maya, T- Shine, and Maxo brands. The Personal Care segment provides body soaps, toothpastes, deodorants, talcum powders, after shave products, and hand washes under the Margo, FA, and Neem Active brands. The Others segment offers incense sticks under the Maya brand; and toilet and floor cleaner products. The company also provides dry cleaning and laundry services under the Fabric Spa brand. The company was formerly known as Jyothy Laboratories Limited and changed its name to Jyothy Labs Limited in July 2019. Jyothy Labs Limited was founded in 1983 and is based in Mumbai, India.

Valuation

Market Cap
β‚Ή0.00
β€”
Current Price
β‚Ή0
β€”as of 15 Sept 2026
P/E Ratio
0.0x
β€”
P/B Ratio
0.0x
β€”
EV / EBITDA
0.0x
β€”
EV / Sales
0.0x
β€”
52W High
β‚Ή0
β€”
52W Low
β‚Ή0
β€”
Shares Out
0.00 Cr
β€”

Profitability

Operating Margin
0.0%
β€”
Net Profit Margin
0.0%
β€”
EBITDA Margin
0.0%
β€”

Returns

ROE
0.0%
β€”
ROCE
0.0%
β€”
ROIC %
β€”
β€”
ROA
0.0%
β€”
Dividend Payout
0.0%
β€”

Solvency

Current Ratio
0.0x
β€”
Debt / Equity
0.0x
β€”
Debt / Assets
0.0x
β€”
CFO / Net Profit
0.0x
β€”
Interest Coverage
0.0x
β€”

AI Summary

Indian Stock

Strengths1

  • Strong 5-year net profit CAGR of 18.6%

Concerns1

  • Negative free cash flow (β‚Ή7 Cr)

Rule-based from financial data. Not advice.

Price Historyβ–Ό 40.98% over 1Y

Monthly Returns

Unlock Monthly Returns

Available on Pro and Institutional plans.

Sign up free

Year-to-Date ROI

Unlock Year-to-Date ROI

Available on Pro and Institutional plans.

Sign up free

Historical Volatility

Unlock Historical Volatility

Available on Pro and Institutional plans.

Sign up free

Historical Performance

Revenue, profitability, and cash flow trends (β‚Ή Crores)

Revenue (10Y)

Operating Income (10Y)

Net Profit (10Y)

Operating Margin % (10Y)

Dividend Payout % (10Y)

Free Cash Flow (10Y)

Growth Summary

Latest fiscal year: Mar 2025

Revenueβ‚Ή2.84 K Crβ–² 3.3%
EBITDA Growthβ€”
Net Profitβ‚Ή371.00 Crβ–² 0.3%
Cash from Ops (CFO)β€”
Free Cash Flow (FCF)β€”β–Ό 66.7%
Revenue CAGR 5Y10.6%
EBITDA CAGR 5Y15.0%
Net Profit CAGR 5Y18.6%
NP Growth 1Y0.3%

Historical Growth

Year-by-year revenue, profitability, and cash flow (β‚Ή Crores, last 10 years)

YearRevenueOp. IncomeNet ProfitCFOFCFROERev Growth 1YNP Growth 1Y
Mar 2025β‚Ή2.84 K Crβ€”β‚Ή371.00 Crβ€”β€”26.8%3.3%0.3%
Mar 2024β‚Ή2.75 K Crβ€”β‚Ή370.00 Crβ€”β€”32.4%11.0%54.2%
Mar 2023β‚Ή2.48 K Crβ€”β‚Ή240.00 Crβ€”β€”27.2%13.2%72.7%
Mar 2022β‚Ή2.19 K Crβ€”β‚Ή139.00 Crβ€”β€”19.0%16.3%-26.8%
Mar 2021β‚Ή1.89 K Crβ€”β‚Ή190.00 Crβ€”β€”20.3%13.2%20.3%
Mar 2020β‚Ή1.67 K Crβ€”β‚Ή158.00 Crβ€”β€”21.2%-5.9%-18.1%
Mar 2019β‚Ή1.77 K Crβ€”β‚Ή193.00 Crβ€”β€”22.6%8.8%19.9%
Mar 2018β‚Ή1.63 K Crβ€”β‚Ή161.00 Crβ€”β€”23.6%-0.4%-20.3%
Mar 2017β‚Ή1.63 K Crβ€”β‚Ή202.00 Crβ€”β€”30.9%5.8%169.3%
Mar 2016β‚Ή1.54 K Crβ€”β‚Ή75.00 Crβ€”β€”15.9%7.2%-47.6%

Financial Statements

Income statement, balance sheet, and cash flow (β‚Ή Crores, as reported)

Free plan Β· showing 1 year of data.Upgrade

Consolidated Figures in USD Millions.

Unnamed: 0TTM
Revenue / Net Sales2,857
Total Expenses2,387
EBIT / Operating Profit470
OPM %16%
Other Income62
Finance Costs6
Depreciation & Amortisation59
Profit Before Tax468
Tax %-
Net Profit / PAT349
EPS (β‚Ή)9.51
Dividend Payout %-

Peer Comparison

Healthcare sector peers, ranked by market cap

CompanyMarket CapRevenueP/EP/BEV/EBITDARev G 1Y
JYOTHY LABS LIMITEDthis co.β‚Ή9.55 K Crβ‚Ή2.84 K Cr27.206.6317.593.3%
Sun Pharmaceutical Industries Ltd.β‚Ή4.15 L Crβ‚Ή23.00 K Cr88.7017.4372.3013.5%
Divi's Laboratories Ltd.β‚Ή1.71 L Crβ‚Ή9.20 K Cr67.9011.1367.2120.0%
Torrent Pharmaceuticals Ltd.β‚Ή1.33 L Crβ‚Ή9.68 K Cr62.5015.7645.6413.5%
Cipla Ltd.β‚Ή1.17 L Crβ‚Ή19.05 K Cr22.503.5119.3314.9%
Apollo Hospitals Enterprises Ltd.β‚Ή1.05 L Crβ‚Ή8.20 K Cr75.0011.2854.4412.8%
Max Healthcare Institute Limitedβ‚Ή1.00 L Crβ‚Ή2.66 K Cr144.0011.7696.8413.8%
Industry Averageβ€”β‚Ή3.29 K Cr98.638.1165.5020.2%

Learn while you research

Hand-picked academy chapters to deepen your understanding of JYOTHY LABS LIMITED and the metrics that matter.

Browse the full Equiscale Academy